Gemcitabine
Top View
- Intravesical Gemcitabine and Mitomycin C Chemotherapy
- Prognosis Small Cell Lung Cancer
- Nab-Paclitaxel and Gemcitabine As First-Line Treatment of Advanced Or Metastatic Cholangiocarcinoma
- Triplet Chemotherapy with Docetaxel, Gemcitabine and Liposomal
- Chondroitin Sulphate Enhances the Antitumor Activity of Gemcitabine and Mitomycin-C in Bladder Cancer Cells with Different Mechanisms
- Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer
- Silverback Care Management CARE N' CARE Specialty Drug
- Feasibility of 21-Day Continuous Infusion of Epirubicin in Hormone-Refractory Prostate Cancer Patients
- Chemotherapy Extravasation Management
- Hydroxyurea [CAS No
- Nab-Paclitaxel (Abraxane) and Gemcitabine for Pancreatic Adenocarcinoma
- Gemcitabine-Paclitaxel Albumin Bound (Abraxane) Ver1
- Bladder Cancer Treatment Regimens
- Epigenetic Cancer Therapy: Rationales, Targets and Drugs
- Gemcitabine/Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: a European Multicenter Study
- Gemcitabine and Cisplatin for Palliative Therapy of Urothelial
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
- Dacogen EMA Public Assessment Report